Advisory Board

Our experts are highly respected authorities in the biosimilars and healthcare industries, including health economics experts, pharmacists, managed care professionals, and key clinical specialists. We are the authoritative resource for emerging therapies.

Joseph P. Fuhr, Jr., PhD

Professor Emeritus
Widener University

Erin Hohman, PharmD, BCPS

Director of Clinical Pharmacy Services
Amber Pharmacy

Jim M. Koeller, MS

Eli Lilly & C.R. Sublett Fellow
Professor of Pharmacotherapy
Pharmacotherapy Education & Research Center
University of Texas Health Science Center San Antonio

Larry LaMotte

Vice President of Public Policy
The Immune Deficiency Foundation

Molly Billstein Leber, PharmD, BCPS, FASHP

Manager
Medication Policy and Formulary Management
Yale New Haven Health System

Brian Lehman, MBA, MHA, RPh

Strategic Consultant
Humana Pharmacy Professional Affairs

Edward Li, PharmD, MPH, BCOP

Associate Professor
Department of Pharmacy Practice
University of New England College of Pharmacy

Rick Lozano

Vice President
Biosimilars and Integrated Business Development
AmerisourceBergen

Steven Lucio, PharmD, BCPS

Associate Vice President
Clinical Solutions and Pharmacy Program Development
Vizient

Ali McBride, PharmD, MS, BCPS

Clinical Coordinator Hematology/Oncology
The University of Arizona Cancer Center

Sonia T. Oskouei, PharmD

Director of Pharmacy Program Development - Biosimilars
Premier Inc

Kashyap Patel, MD

Medical Oncologist
Carolina Blood and Cancer Care

Ronald A. Rader

President
Biotechnology Information Institute

Hope Rugo, MD

Clinical Professor
Department of Medicine (Hematology/Oncology)
Director
Breast Oncology Clinical Trials Program
University of California at San Francisco

Gregory F. Schimizzi, MD

Carolina Arthritis Associates

Kyle F. Skiermont, PharmD

COO
Fairview Pharmacy Services

Marcus Snow, MD

Assistant Professor of Internal Medicine
Division of Rheumatology
University of Nebraska Medical Center

James G. Stevenson, PharmD, FASHP

Professor
Department of Clinical Pharmacy
University of Michigan College of Pharmacy

Ha Kung Wong, JD

Partner
Fitzpatrick, Cella, Harper & Scinto

If you are interested in becoming a contributor and adding your voice to the conversation, contact our Associate Editorial Director or our Senior Editor.

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2017 Intellisphere, LLC. All Rights Reserved.